Aleksandra Bankovacki

Melbourne, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.

CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.

Journal: The British journal of dermatology

Published: July 18, 2022

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.

Journal: EMBO reports

Published: March 11, 2020

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.

Journal: The EMBO journal

Published: October 14, 2019

Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy.

Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy.

Journal: The EMBO journal

Published: June 01, 2018

IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans.

IAPs Regulate Distinct Innate Immune Pathways to Co-ordinate the Response to Bacterial Peptidoglycans.

Journal: Cell reports

Published: July 27, 2017

Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.

Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.

Journal: Nature microbiology

Published: February 14, 2017

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.

Journal: Nature microbiology

Published: October 19, 2016

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.

A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.

Journal: Nature communications

Published: September 09, 2014

cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner.

cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner.

Journal: Blood

Published: February 06, 2014

Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1.

Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1.

Journal: Immunology and cell biology

Published: July 23, 2013

A type III effector antagonizes death receptor signalling during bacterial gut infection.

A type III effector antagonizes death receptor signalling during bacterial gut infection.

Journal: Nature

Published: April 08, 2013

IAPs limit activation of RIP kinases by TNF receptor 1 during development.

IAPs limit activation of RIP kinases by TNF receptor 1 during development.

Journal: The EMBO journal

Published: October 17, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026